These results confirm that obesity could accumulate epigenetic marks, including DNA methylation and microRNAs plasma changes that, in turn, might alter the expression of inflammatory molecules and suggest for the first time a role of specific epigenetic modifications as a potential mechanism underlying the anti-inflammatory properties and cardiovascular benefits of adiponectin. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.